Technology | Artificial Intelligence | November 07, 2018

MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform

Artificial intelligence software developed to enhance acute care physician’s ability to identify and prioritize brain bleed, stroke or head trauma

MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform

November 7, 2018 – MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The clearance paves the way for healthcare providers and physicians in acute care settings to have access to this artificial intelligence (AI) software designed to aid in prioritizing the clinical assessment of adult non-contrast head computed tomography (CT) cases that exhibit indications of intracranial hemorrhage (ICH), commonly known as a brain bleed.

Earlier this year, MaxQ announced CE Mark approval and commercial availability in the European Union. The software leverages artificial intelligence technology to automatically analyze non-contrast head CT images without workflow impact to the reader, altering the original series or storing protected health information (PHI). The AI-powered Accipio Ix, part of MaxQ’s Accipio Insight platform, is designed to be highly sensitive to the presence of ICH, identifying and prioritizing patients with ICH for the treating physician. It provides a capability for rapid escalation and prioritization of the patient, and can be natively integrated into CT and picture archiving and communication systems (PACS) using the imaging industry-standard DICOM, installed both on-premise and cloud-capable.

MaxQ will be demonstrating Accipio Ix – along with the full suite of Accipio platform solutions – during the Radiological Society of North America (RSNA) 2018 Annual Meeting, Nov. 25-30 in Chicago.

For more information: www.maxq.ai

Related Content

Partners HealthCare Chooses Visage 7 for Enterprise Imaging
News | Enterprise Imaging | January 18, 2019
Visage Imaging Inc. announced the signing of Partners HealthCare, the largest health system in Massachusetts, for...
Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Philips Launches Azurion With FlexArm
Technology | Angiography | January 17, 2019
Philips announced the launch of Azurion with FlexArm, designed to enhance positioning flexibility for image-guided...
Seamless Interoperability – Fact or Fiction? This webinar will show how Nemours Children’s Health System adoption of ScImage’s PICOM365 Enterprise PACS  improved workflow. The product will be highlighted at HIMSS 2019.
Sponsored Content | Webinar | PACS | January 17, 2019
This ScImage-sponsored ITN/DAIC webinar will be held at 2 p.m. Eastern time, Wednesday, Feb. 6, 2019.
NewYork-Presbyterian Hospital Partners With Philips for Health IT and Clinical Informatics
News | Enterprise Imaging | January 16, 2019
Philips announced that NewYork-Presbyterian Hospital has chosen to implement the company’s IntelliSpace Enterprise...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Sponsored Content | Videos | Artificial Intelligence | January 15, 2019
ITN Contributing Editor Greg Freiherr offers an overview of...
Sponsored Content | Videos | Enterprise Imaging | January 14, 2019
ITN Contributing Editor Greg Freiherr offers an overview of enterprise
Machine Learning Uncovers New Insights Into Human Brain Through fMRI
News | Neuro Imaging | January 11, 2019
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully...
Videos | Interventional Radiology | January 11, 2019
Julius Chapiro, M.D., research faculty member and an...